Kamiya Biomedical Company

What Kamiya Biomedical Company does

Kamiya Biomedical Company is a privately-held life science and clinical diagnostics company headquartered in Seattle, Washington. Founded in March 1983 by Kohji Kamiya in Thousand Oaks, California and relocated to Seattle in 1996, the company develops, manufactures, and distributes a diversified catalog of biological reagents across two primary pillars: the K-ASSAY branded line of immunoturbidimetric clinical diagnostic reagents designed to run on standard automated chemistry analyzers, and a life science research portfolio encompassing thousands of ELISA kits, more than 1,300 monoclonal and polyclonal antibodies, over 200 biochemicals, and approximately 300 other research products including colorimetric and fluorescent assays.

The core technology is latex-enhanced immunoturbidimetric assay methodology, applied to clinical chemistry analyzer platforms from Roche, Cobas, Hitachi, Beckman, Olympus, Siemens, and Abbott. K-ASSAY reagents are formulated as liquid, ready-to-use products requiring no reconstitution, and the company reports correlation coefficients of r = 0.98–0.999 against reference methods across analytes including RF, CRP, Ferritin, and Beta-2 Microglobulin. Kamiya positions itself as having the broadest U.S. portfolio of liquid serum protein immunoassay reagents and as a world leader in preclinical/animal ELISA kits with unique species combinations not offered by major competitors. The company holds ISO 13485 certification for medical device manufacturing and CE Mark certification for EU IVD Directive compliance.

Commercially, Kamiya generates revenue through one-time unit sales of reagents and kits via direct phone, fax, and email ordering and an international distributor network spanning Europe, Asia, Africa, Oceania, and the Americas. Pricing is per unit, with research ELISA kits ranging from approximately $561.60 to $1,287 per kit and antibodies from $324 to $564. The firm also offers laboratory testing services for lipid and Vitamin C analysis with turnaround-time-based delivery. Despite a 40+ year operating history, the company remains founder-led and privately held with a 1–10 employee footprint and no disclosed external funding, acquisitions, or M&A activity.

Name

Kamiya Biomedical Company

Legal name

Kamiya Biomedical Company

Website

https://kamiyabiomedical.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

1–10 employees

Short description

Kamiya Biomedical Company is a privately-held Seattle-based life science and clinical diagnostics company that manufactures and distributes K-ASSAY immunoturbidimetric reagents, ELISA kits, antibodies, and biochemicals through direct sales and an international distributor network serving hospitals, clinical labs, and academic research facilities.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Clinical diagnostic reagents
• Immunoturbidimetric immunoassays
• Research ELISA kits
• Monoclonal and polyclonal antibodies
• Preclinical animal diagnostics

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Diagnostic Reagents: K-ASSAY immunoassay reagents for chemistry analyzers sold directly and through distributors. Includes reagents, calibrators, and controls for clinical diagnostics.
2. Research ELISA Kits: Thousands of ELISA kits for research use testing of human and animal samples sold through direct ordering and international distributors.
3. Antibodies: Over 1,300 monoclonal and polyclonal antibodies for various research applications including immunocytochemistry, immunohistochemistry, Western Blot, and ELISA.
4. Biochemicals: Over 200 biochemicals including recombinants, substrates, inhibitors, polymerases, inducers, and other research products.
5. Other Research Products: Nearly 300 other research products including alternatives to ELISA assays such as colorimetric and fluorescent assays, cell culture and cryopreservation kits.
6. Laboratory Testing Services: Lipid and Vitamin C testing services for research and preclinical studies.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Kamiya Biomedical Company manufactures and supplies the K-ASSAY line of liquid, ready-to-use immunoturbidimetric immunoassay reagents for major automated clinical chemistry analyzers, used to quantitatively measure clinical biomarkers (CRP, RF, D-Dimer, Ferritin, Beta-2 Microglobulin, KL-6, apolipoproteins, H. pylori, etc.) in patient serum, plasma, or urine. The company also offers an extensive catalog of research ELISA kits, animal/preclinical ELISA kits, more than 1,300 antibodies, over 200 biochemicals, and lipid and Vitamin C laboratory testing services for life science and preclinical research customers.

Product overview

Kamiya Biomedical Company is a life science and clinical diagnostics company offering a diversified portfolio of biological reagents and testing services. The core product lines include K-ASSAY immunoassay reagents for automated clinical chemistry analyzers, Research ELISA kits for human biomarker detection, and Animal/Preclinical ELISA kits for veterinary research. These are complemented by over 1,300 antibodies, more than 200 biochemicals, and nearly 300 other research products. The company also provides laboratory testing services for lipid and Vitamin C analysis. All K-ASSAY products use immunoturbidimetric technology and are designed to work with standard chemistry analyzers from major manufacturers. The company operates primarily through direct sales and international distributors, with no API offering.

Differentiator

Problem solved

Functional benefit

Brands

• K-ASSAY: Brand name for immunoassay reagents for clinical diagnostics on chemistry analyzers, including reagents for CRP, D-Dimer, Ferritin, IgA, IgG, IgM, Beta-2 Microglobulin, RF, KL-6, H. pylori, RLP-C, and other analytes.
• K-ASSAY Antibodies
• KAMIYA Research ELISA Kits
• KAMIYA Preclinical/Animal ELISAs

Products and services

• K-ASSAY Immunoassay Reagents Liquid, ready-to-use immunoturbidimetric assay reagents for automated clinical chemistry analyzers (Roche/Cobas, Hitachi, Beckman, Olympus, Siemens, Abbott), used for the quantitative measurement of clinical biomarkers such as CRP, RF, D-Dimer, Ferritin, Beta-2 Microglobulin, KL-6, apolipoproteins, IgA/IgG/IgM, and H. pylori in patient serum, plasma, or urine. Sold to clinical laboratories, hospitals, medical centers, and reference labs. ISO 13485 and CE Mark certified.
• Research ELISA Kits ELISA kits for quantitative detection of biomarkers in human samples for research use, spanning numerous research interests including cytokines, growth factors, cancer markers, virus infection targets, cytokine storm targets, angiogenesis, apoptosis, cardiac health, and inflammation. Includes many esoteric and difficult-to-find tests.
• Animal / Preclinical ELISA Kits
• Antibodies
• Biochemicals
• Other Research Products
• Laboratory Testing Services
• COVID-19 Research Reagents
• Animal Assay Reagents for Chemistry Analyzers

Quantifiable outcome

• Correlation r = 0.989 vs competitor RF assays
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• International Distributor NetworkcoreChannel Partner/ Reseller/ DistributorKAMIYA maintains an extensive international distribution network covering Europe (UK, Germany, Italy, Austria, Czech Republic, Denmark, Finland, Greece, Sweden, Norway, Switzerland, Slovakia, Estonia, Latvia, Lithuania), Asia (Singapore, Taiwan, Vietnam, UAE, Kuwait, Lebanon, Qatar), Africa (Libya), Oceania (Australia, New Zealand), North America (Puerto Rico), and South America (Dominican Republic, Venezuela) for clinical diagnostic products.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher supplies research ELISA kits, antibodies, biochemicals, and clinical diagnostics reagents across a vastly broader portfolio. Kamiya's specialized offerings are a small, niche alternative within Thermo Fisher's research products division.
• Roche Diagnostics: Roche Diagnostics is the dominant global supplier of clinical chemistry analyzers and closed-system immunoassay reagents (cobas line), competing with Kamiya at the instrument-reagent level. Kamiya's analyzer-agnostic reagents specifically target labs seeking to use Roche instruments with non-Roche consumables.
• Abbott Diagnostics: Abbott Diagnostics sells automated clinical chemistry analyzers (Architect, Alinity) with proprietary immunoassay reagents, competing with Kamiya's K-ASSAY reagents that run on Abbott platforms as a third-party alternative.

Direct peers

• Abcam: Abcam is a major supplier of antibodies and research reagents with a catalog of hundreds of thousands of products, directly competitive with Kamiya's 1,300+ antibody offering and broader life science reagent portfolio.
• Diazyme Laboratories: Diazyme develops and manufactures clinical chemistry reagents and immunoassays for automated analyzers, directly competing with Kamiya's K-ASSAY reagent line in clinical diagnostics. Both companies specialize in liquid ready-to-use reagents compatible with major chemistry analyzer platforms.
• EKF Diagnostics: EKF Diagnostics develops and distributes clinical chemistry reagents, immunoassays, and point-of-care diagnostics. Its specialty clinical chemistry reagents compete with Kamiya's K-ASSAY clinical diagnostic portfolio.
• Enzo Life Sciences: Enzo Life Sciences offers ELISA kits, antibodies, biochemicals, and assay kits for research use, competing directly with Kamiya's life science research product lines including colorimetric, fluorescent, and immunoassay products.
• Cayman Chemical: Cayman Chemical manufactures ELISA kits, antibodies, biochemicals, and specialty reagents for life science research, with comparable catalog breadth and academic/industrial customer overlap to Kamiya's research division.
• R&D Systems (Bio-Techne): Bio-Techne's R&D Systems brand is a global leader in research ELISA kits, antibodies, and biochemicals, directly overlapping Kamiya's research product portfolio across thousands of human biomarker assays and ancillary reagents.
• Sekisui Diagnostics: Sekisui Diagnostics supplies clinical chemistry and immunoassay reagents for automated analyzers, including coagulation and specialty proteins. It competes head-to-head with Kamiya in clinical chemistry reagents for hospital and reference lab customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/kamiya-biomedical-co

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kamiya Biomedical Company